Non-clinical safety profile and pharmacodynamics of two formulations of the anti-sepsis drug candidate Rejuveinix (RJX)

Publication date: September 2021Source: Biomedicine & Pharmacotherapy, Volume 141Author(s): Fatih M. Uckun, Cemal Orhan, Joy Powell, Emre Sahin, Ibrahim H. Ozercan, Michael Volk, Kazim Sahin
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research